View in EDS

161P Population effectiveness model of the consequences of recurrence after trastuzumab emtansine (T-DM1) treatment among U.S. patients with high-risk HER2+ early-stage breast cancer (ESBC).

Saved in:
Bibliographic Details
Title: 161P Population effectiveness model of the consequences of recurrence after trastuzumab emtansine (T-DM1) treatment among U.S. patients with high-risk HER2+ early-stage breast cancer (ESBC).
Authors: Veenstra, D.L.1 (AUTHOR), Hendrix, N.2 (AUTHOR), Dolan, C.M.3 (AUTHOR), Fisher, K.A.3 (AUTHOR), Lalla, D.4 (AUTHOR), Oestreicher, N.5 (AUTHOR), Moy, B.6 (AUTHOR)
Source: Annals of Oncology. 2021 Supplement 5, Vol. 32, pS430-S431. 2p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 152688790
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 161P Population effectiveness model of the consequences of recurrence after trastuzumab emtansine (T-DM1) treatment among U.S. patients with high-risk HER2+ early-stage breast cancer (ESBC).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Veenstra%2C+D%2EL%2E%22">Veenstra, D.L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hendrix%2C+N%2E%22">Hendrix, N.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dolan%2C+C%2EM%2E%22">Dolan, C.M.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fisher%2C+K%2EA%2E%22">Fisher, K.A.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lalla%2C+D%2E%22">Lalla, D.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Oestreicher%2C+N%2E%22">Oestreicher, N.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moy%2C+B%2E%22">Moy, B.</searchLink><relatesTo>6</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2021 Supplement 5, Vol. 32, pS430-S431. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152688790
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2021.08.442
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S430
    Titles:
      – TitleFull: 161P Population effectiveness model of the consequences of recurrence after trastuzumab emtansine (T-DM1) treatment among U.S. patients with high-risk HER2+ early-stage breast cancer (ESBC).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Veenstra, D.L.
      – PersonEntity:
          Name:
            NameFull: Hendrix, N.
      – PersonEntity:
          Name:
            NameFull: Dolan, C.M.
      – PersonEntity:
          Name:
            NameFull: Fisher, K.A.
      – PersonEntity:
          Name:
            NameFull: Lalla, D.
      – PersonEntity:
          Name:
            NameFull: Oestreicher, N.
      – PersonEntity:
          Name:
            NameFull: Moy, B.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2021 Supplement 5
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 32
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1